皮塔瓦斯塔丁在失脂症中的成本效益分析:越南案例
Nam Xuan Vo1, Hanh Thi My Nguyen1, Nhat Manh Phan1
1Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam.
Healthcare (Basel, Switzerland)
|October 16, 2025
概括
皮塔瓦斯塔丁是越南治疗脱脂症的经济有效的他类药物,与阿托瓦斯塔丁相比,它提供了经济上的好处. 虽然不优于罗斯瓦斯塔丁,但其经济实惠性使其成为资源有限的医疗保健机构中可行的选择.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 心血管疾病管理管理
背景情况:
- 脱脂症在低收入至中等收入国家 (LMICs) 构成重大经济负担,导致心血管疾病死亡率.
- 包括皮塔瓦斯塔丁在内的他类药物是降低LDL-C和管理心血管疾病成本的第一线治疗方法.
研究的目的:
- 在越南进行皮塔瓦斯塔丁的成本效益分析.
- 为了确定与阿托瓦斯塔丁和罗斯瓦斯塔丁相比,皮塔瓦斯塔丁的经济益处.
主要方法:
- 一个决策树模型被用来比较皮塔瓦斯塔丁,阿托瓦斯塔丁和罗斯瓦斯塔丁在一生的时间范围内.
- 主要结果是从医疗保健系统的角度看的增量成本效益比率 (ICER).
- 经质量调整的寿命年 (QALYs) 用于衡量有效性,年折扣率为3%.
主要成果:
- 与阿托瓦斯塔丁相比,Pitavastatin被发现具有成本效益,ICER低于越南的支付意愿门.
- 在获得的QALY方面,皮塔瓦斯塔丁被罗斯瓦斯塔丁主导.
- 药物成本被确定为影响ICER结果的最有影响力的参数.
结论:
- 皮塔瓦斯塔丁在越南为阿托瓦斯塔丁提供了一个经济的短期替代品.
- 它的成本效益使得它成为在资源有限的环境中适合治疗脱脂症的合适选择.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Coronary Artery Disease V: Interprofessional Care
212
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
212

